Arsenene Nanodots with Selective Killing Effects and their Low‐Dose Combination with ß‐Elemene for Cancer Therapy (Adv. Mater. 37/2021)

Abstract

Arsenical Drugs In article number 2102054, Aiguo Wu, Tian Xie, Wei Tao, and co-workers reveal PEGylated arsenene nanodots (AsNDs@PEG) with high monoelemental arsenic purity and negligible systemic toxicity as a new-concept arsenical drug. This AsNDs@PEG, when applied in a low-dose combination strategy with β-elemene, a plant-derived anticancer drug, achieves synergistic therapeutic outcomes.